Meyka Pro banner
ICON Public Limited Company

ICON Public Limited Company (ICLR) Stock Overview

Explore ICON Public Limited Company’s financial performance, market position, analyst ratings, and future outlook.

ICLRNASDAQ
HealthcareMedical - Diagnostics & Research
$163.51
$6.66(4.25%)
U.S. Market opens in 12h 46m

ICON Public Limited Company (ICLR)

Meyka AI Score

Z

Key Financials

Market Cap12.5B
P/E Ratio38.17
EPS (TTM)$12.26
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$166.85
3 Months$194.77
1 Year Target$155.67

ICLR Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of ICON Public Limited Company (NASDAQ: ICLR) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, ICON Public Limited Company's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ICLR on the NASDAQ shows an RSI of 49.42, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $155.67 for the NASDAQ listing.

Key metrics behind ICON Public Limited Company's NASDAQ-traded stock include a P/E ratio of 38.17 and a market capitalization of 12.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ICLR on the NASDAQ.

Price Performance (NASDAQ: ICLR)

1-Day Change
4.25%
5-Day Change
-1.17%
1-Month Change
-4.35%
3-Month Change
34.78%
6-Month Change
12.46%
Year-to-Date (YTD) Change
-10.27%
1-Year Change
-1.49%
3-Year Change
-35.00%
5-Year Change
-32.86%
All-Time (Max) Change
2471.16%

Contact Information

353 1 291 2000
South County Business Park, Dublin, DU, D18 X5R3

Company Facts

401,000 Employees
IPO DateMay 15, 1998
CountryIE
Actively Trading

Frequently Asked Questions